These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4809261)

  • 1. Synthesis and some pharmacological properties of 8-epsilon-hydroxynorleucine-vasopressin.
    Dreyfuss P
    J Med Chem; 1974 Feb; 17(2):252-5. PubMed ID: 4809261
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and hormonal activities of 8-L-homolysine-vasopressin.
    Bodanszky M; Lindeberg G
    J Med Chem; 1971 Dec; 14(12):1197-9. PubMed ID: 5116234
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and hormonal activities of 8-L-homonorleucine-vasopressin.
    Fink ML; Bodanzky M
    J Med Chem; 1973 Dec; 16(12):1324-6. PubMed ID: 4765858
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and properties of 1-deamino-8-L-homolysine-vasopressin.
    Lindeberg G; Kyncl J; Dreyfuss P; Bodanszky M
    J Med Chem; 1972 Jun; 15(6):629-31. PubMed ID: 5030930
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and some of the pharmacological properties of (4-leucine)-8-lysine-vasopressin and (1-deamino,4-leucine)-8-lysine-vasopressin.
    Dyckes DF; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1973 Jul; 16(7):843-7. PubMed ID: 4725931
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and some pharmacological properties of 8-L-homoarginine-vasopressin and of 1-deamino-8-L-homoarginine-vasopressin.
    Lindeberg G; Bodanszky M; Acosta M; Sawyer WH
    J Med Chem; 1974 Jul; 17(7):781-3. PubMed ID: 4836417
    [No Abstract]   [Full Text] [Related]  

  • 7. Solid phase synthesis of (1-deamino,4-valine)-8-D-arginine-vasopressin (DVDAVP), a highly potent and specific antidiuretic agent possessing protracted effects.
    Manning M; Balaspiri L; Acosta M; Sawyer WH
    J Med Chem; 1973 Sep; 16(9):975-8. PubMed ID: 4745513
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and certain pharmacological properties of lysine-vasopressinoic acid methylamide and lysine-vasopressinoic acid dimethylamide.
    Glass JD; du Vigneaud V
    J Med Chem; 1972 May; 15(5):486-8. PubMed ID: 5064318
    [No Abstract]   [Full Text] [Related]  

  • 9. (1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V
    J Med Chem; 1974 Feb; 17(2):250-2. PubMed ID: 4809260
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-phase synthesis and some pharmacological properties of 4-threonine analogs of vasopressins and vasotocin and of arginine-vasopressin and arginine-vasotocin.
    Manning M; Coy EJ; Sawyer WH; Acosta M
    J Med Chem; 1973 May; 16(5):463-6. PubMed ID: 4718457
    [No Abstract]   [Full Text] [Related]  

  • 11. Solid-phase synthesis and pressor potency of (1-deamino-9-ethylenediamine)-lysine-vasopressin.
    Glass JD; Du Vigneaud V
    J Med Chem; 1973 Feb; 16(2):160-1. PubMed ID: 4683112
    [No Abstract]   [Full Text] [Related]  

  • 12. Solid-phase synthesis and some pharmacological properties of deamino-4-threonine analogs of the vasopressins and vasotocin and (deamino)arginine-vasotocin.
    Manning M; Coy EJ; Acosta M; Sawyer WH
    J Med Chem; 1973 Jul; 16(7):836-9. PubMed ID: 4542167
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacology of oxytocin-(1-6)-hexapeptide amide, vasopressin-(1-6)-hexapeptide amide and their deamino analogues.
    Krejcí I; Barth T; Kupková B; Fruhaufová L; Flegel M; Zaoral M
    Eur J Pharmacol; 1973 Nov; 24(2):179-82. PubMed ID: 4797284
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis of a cystine peptide with structural characteristics of lysine-vasopressin].
    Rimpler M
    Naturwissenschaften; 1973 Nov; 60(11):520. PubMed ID: 4767471
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of the substitution of photoreactive groups in positions 4 and 8 of vasopressin.
    Buku A; Yamin N; Gazis D
    Int J Pept Protein Res; 1989 Jul; 34(1):28-32. PubMed ID: 2507457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of desglycinamide lysine vasopressin and its behavioral activity in rats.
    Wang SS
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1511-5. PubMed ID: 5077834
    [No Abstract]   [Full Text] [Related]  

  • 17. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 18. Vasopressin analogs with high and specific antidiuretic activity.
    Zaoral M
    Int J Pept Protein Res; 1985 Jun; 25(6):561-74. PubMed ID: 3897085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 20. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.